Quince Therapeutics, Inc. (QNCX)
1.145
-0.04
(-2.97%)
USD |
NASDAQ |
May 15, 12:37
Quince Therapeutics Total Assets (Quarterly) : 26.62M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.340B |
| BioXcel Therapeutics, Inc. | 47.52M |
| Gossamer Bio, Inc. | 172.25M |
| Ernexa Therapeutics, Inc. | 10.54M |
| Acurx Pharmaceuticals, Inc. | 9.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.95M |
| Shareholders Equity (Quarterly) | 15.67M |
| Debt to Equity Ratio | 0.0259 |
| Current Ratio | 2.917 |
| Net Debt Paydown Yield | 50.99% |